ArticleFuture oncology (London, England)2025

Prognostic factors of long-term response to androgen receptor signaling inhibitors used as first-line treatment for mCRPC.

Antonello Veccia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.